Emphysema |
Pulmonary Emphysema |
Clinical Trial: Efficacy of Osteopathic Manipulation in Chronic Obstructive Pulmonary Disease
This study is no longer recruiting patients.
|
Purpose
The purpose of this study is to determine if osteopathic manipulative treatment (OMT) is effective for persons with emphysema as a component of their chronic obstructive pulmonary disease.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Emphysema | Procedure: osteopathic manipulative treatment | Phase II |
MedlinePlus related topics: Emphysema
Study Type: Interventional
Study Design: Treatment, Randomized, Placebo Control
Study start: April 2001; Study completion: March 2002
OMT sessions are designed to improve chest wall compliance and diaphragmatic function which produce an immediate positive change in pulmonary function parameters and chest wall mobility. This research project will be a significant step in expanding the understanding of the role of OMT in the treatment of chronic lung disease. It is expected to yield evidence that OMT is an important adjunctive modality that improves pulmonary function, increases exercise tolerance, relieves dyspnea, and improves quality of life in those with COPD, and that would have widespread clinical application plus significant economic benefits.
Participants in this study will be randomly assigned to receive either OMT or sham treatments once a week for 13 weeks. Outcome measures will be obtained at baseline; immediately following the first treatment; at 4, 8, and 12 weeks after initiation of treatment; and 4 weeks after termination of the treatment. Outcome variables include pulmonary function tests; quality-of-life questionnaires (including emotional functioning, fatigue, and dyspnea); and measurements of exercise tolerance and chest wall mobility.
Eligibility
Location Information
Missouri
Kirksville College of Osteopathic Medicine, Kirksville, Missouri, 63501, United States
More Information
Record last reviewed: March 2004
Last Updated: October 13, 2004
Record first received: April 22, 2002
ClinicalTrials.gov Identifier: NCT00034112
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- A1AD Related Emphysema (American Lung Association)
- Alpha-1 Related Emphysema (American Lung Association)

Not Signed In -

